Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the investigator after signing informed consent. Subject numbers of discontinued subjects must not be re-used (i.e., subject replacement is not allowed). Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the investigator, continued treatment poses a risk to their health. For subjects discontinuing from the study, the investigator must complete all Exit procedures according to Table 3-1 Schedule of Study Procedures and Assessments if the subject is willing and able, and if in the opinion of the investigator it is safe for the subject to do so. The investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. Nothing in this Agreement precludes the Corporation from at any time discontinuing the sale of any Product which the Corporation concludes in its sole discretion is no longer profitable or otherwise feasible for the Corporation to sell.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the Investigator after signing the informed consent. Subject numbers of discontinued subjects must not be re-used. Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the Investigator, continued treatment poses a risk to their health.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the Investigator after signing the informed consent. Subject numbers of discontinued subjects must not be re-used. Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the Investigator, continued treatment poses a risk to their health. For subjects discontinuing from the study, the Investigator must complete all Exit procedures according to Table 3–1, if the subject is willing and able, and if in the opinion of the Investigator it is safe for the subject to do so. The Investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, Investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. The subject is discontinued in the following cases:
Discontinuations. With 90 days written notice, and subject to Supplier's approval (which will not be unreasonably withheld), Buyer may from time to time discontinue existing SKUs.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the investigator after signing the informed consent. Subject numbers of discontinued subjects must not be re-used (i.e., subject replacement is not allowed). Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the investigator, continued treatment poses a risk to their health. If a subject discontinues from study treatment, every effort must be made to keep the subject in the study and to continue with the study assessments as specified in the schedule of study procedures and assessments until the final visit. For subjects discontinuing from the study, the investigator must complete all Exit procedures according to Table 3-1 Schedule of Study Procedures and Assessments and Section 10.4.3, if the subject is willing and able, and if in the opinion of the investigator it is safe for the subject to do so. The investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. Nothing in this Agreement shall preclude Vision X from discontinuing the sale of any Product which Vision X reasonably concludes is no longer profitable or otherwise feasible for Vision X to sell, provided Vision X gives the Reseller at least thirty (30) days prior notice of such discontinuation.
